These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4439354)

  • 1. [Incompatibilities of antibiotics administered by venous infusion].
    Flouvat B; Lechat P
    Therapie; 1974; 29(3):337-56. PubMed ID: 4439354
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 4. The availability of antibiotics in combination with other additives in intravenous solutions.
    Dancey JW; Carew DP
    Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous drug incompatibilities.
    Morris ME
    Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757
    [No Abstract]   [Full Text] [Related]  

  • 6. Remarks about and prospects of the use of antibiotics in hospitals.
    Rondanelli R; Guaglio R; Leonardi V; Cristiani D
    Prog Clin Biol Res; 1979; 35():203-10. PubMed ID: 538033
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 8. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
    Nieves-Cordero AL; Luciw HM; Souney PF
    Am J Hosp Pharm; 1985 May; 42(5):1108-9. PubMed ID: 4003421
    [No Abstract]   [Full Text] [Related]  

  • 9. Incompatibility of piritramide with cephalosporins.
    Eckle VS; Heim E; Hahn M; Grasshoff C
    Ann Pharmacother; 2013 Mar; 47(3):426-7. PubMed ID: 23447484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physical and chemical incompatibilities of drug associations in syringes and perfusion bottles].
    Léopold G
    Anesth Analg (Paris); 1971; 28(5):879-86. PubMed ID: 5158891
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of fluconazole in commonly used intravenous antibiotic solutions.
    Inagaki K; Takagi J; Lor E; Lee KJ; Nii L; Gill MA
    Am J Hosp Pharm; 1993 Jun; 50(6):1206-8. PubMed ID: 8517463
    [No Abstract]   [Full Text] [Related]  

  • 13. Physico-chemical incompatibilities of parenteral admixtures Aramine and Solu-Cortef.
    Anderson RW; Latiolais CJ
    Am J Hosp Pharm; 1970 Jul; 27(7):540-7. PubMed ID: 5431052
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalosporin-pentamidine isethionate incompatibilities.
    Lewis JD; el-Gendy A
    Am J Health Syst Pharm; 1996 Jun; 53(12):1461-2. PubMed ID: 8781694
    [No Abstract]   [Full Text] [Related]  

  • 16. Some incompatibilities of intravenous admixtures.
    Fowler TJ
    Am J Hosp Pharm; 1967 Aug; 24(8):450-7. PubMed ID: 6075730
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk of heavy precipitation of vancomycin in the presence of fluid gelatin in infusion tubes].
    Narbonne H; Mely C; Picard R; Morange S; Lesluyes L; Vialettes B
    Therapie; 1996; 51(5):599. PubMed ID: 9138403
    [No Abstract]   [Full Text] [Related]  

  • 18. The physico-chemical incompatibilities of selected cardiovascular and psychotherapeutic agents with sodium ethacrynate.
    Catania PN; King JC
    Am J Hosp Pharm; 1972 Feb; 29(2):141-6. PubMed ID: 5020599
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability papers and equal publishing opportunities.
    Klein CN
    Am J Hosp Pharm; 1991 Jul; 48(7):1454. PubMed ID: 1882872
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of haloperidol lactate with injectable solutions.
    Fraser GL; Riker RR
    Am J Hosp Pharm; 1994 Apr; 51(7):905-6. PubMed ID: 8017441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.